Previous Article
Infection and Immunity, November 1998, p. 5592-5597, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A Globally Disseminated M1 Subclone of Group A
Streptococci Differs from Other Subclones by 70 Kilobases of
Prophage DNA and Capacity for High-Frequency Intracellular
Invasion
P. P.
Cleary,*
D.
LaPenta,
R.
Vessela,
H.
Lam, and
D.
Cue
Department of Microbiology, University of
Minnesota, Minneapolis, Minnesota
Received 24 April 1998/Returned for modification 2 July
1998/Accepted 10 August 1998
 |
ABSTRACT |
The M1inv+ subclone of M1 group A streptococci that spread globally
in the late 1980s and early 1990s was previously identified by
restriction fragment length polymorphism (RFLP), M protein, and SpeA
exotoxin sequence analyses. Strains representing this subclone were
characterized with regard to carriage of bacteriophage and capacity to
invade cultured human epithelial cells. The M1inv+ subclone was found
to harbor two entirely different prophages, phage T13 and phage T14,
which together supplement its genome with nearly 70 kb of DNA. Phage
T14 encodes the SpeA exotoxin and is closely related to the classic
converting phage T12. Plaque-forming characteristics and RFLP analyses
of phages T13 and T14 were compared to each other and to phage T12.
Other subclones of M1, isolated in the 1970s to the early 1980s, lacked
both prophages. The M1inv+ subclone was previously reported to be
efficiently internalized by human epithelial cells. This potential was
confirmed and expanded by comparing a variety of clinical isolates. The
capacity for high-frequency invasion of epithelial cells was not
transmitted to a laboratory strain of group A streptococci by the
above-mentioned bacteriophages.
 |
TEXT |
Since 1985, numerous geographically
and temporally restricted outbreaks of systemic infections caused by
serotype M1 group A streptococci have been reported (1, 5,
16, 23, 24, 26-29, 32, 34, 36, 37). These outbreaks occurred on
at least five continents of the world. Based on genomic restriction fragment length polymorphism (RFLP), we suggested that a specific subclone or clonal variant of this serotype, designated M1inv+, emerged
in the mid-1980s to become the most-common M1 strain isolated from
cases of uncomplicated pharyngitis (5). This same variant was also associated with the increased incidence of toxic shock in
North America (5, 28), Scandinavia (24, 26, 34), and New Zealand (23). Other M1 subclones, based on
distinctive RFLP, are designated M1inv
for ease of discussion.
Although outbreaks of toxic shock associated with M1 infection
continued to occur in the 1990s, health authorities began to recognize
clusters of toxic shock and necrotizing fasciitis associated with other
serotypes (2, 7, 8, 10). This observation is puzzling but
could be explained by increased awareness of public health authorities, changes in the health status of susceptible populations, or the horizontal dissemination of an unidentified virulence factor for other
serotypes.
The acquisition of plasmids, prophages, or transposons could account
for differences in RFLP and virulence that distinguish M1 subclones.
This streptococcal species seldom harbors plasmids or transposons, but
most strains carry one or more prophages (18, 19, 35, 38,
40). To investigate this possibility, phages were isolated from
an M1inv+ strain and compared to the bacteriophage T12, a known and
well-studied vector of the speA toxin gene (19, 38, 40,
41). Preliminary data suggested that M1inv+ strains invade
cultured human epithelial cells at a significantly higher frequency
than M1inv
strains. This finding was confirmed, and the relationship
between intracellular invasion and prophages carried by M1inv+ strains
was investigated.
Streptococcal cultures were grown and stored as previously described
(6). Fifty-eight group A streptococcal M1 serotype strains
that were isolated from different areas of the United States and the
world were used in this study. Among them, 27 strains were isolated
from individuals with systematic streptococcal disease (toxic shock,
sepsis, or necrotizing fasciitis). Thirty-one strains were isolated
from the throats of patients with uncomplicated pharyngitis. Most
strains were obtained from the World Health Organization Collaborating
Center for Reference and Research on Streptococci at the University of
Minnesota. Strains 89, 80, 68, and 62 are blood isolates that represent
the predominant M1 subclone in Finland and Norway (24, 26,
34). The New Zealand strains, 88-711, 89-385, 85-1532, and
84-221, represent the RFLP Ia subclone and were obtained from D. Martin, Communicable Disease Center, Porirua, New Zealand (23,
28). The T253c strain, which was cured of endogenous
plaque-forming bacteriophages (18, 41), was used as the
recipient strain for phage propagation and the construction of
lysogens. The T253c(phage T12) lysogen served as the donor strain for
the preparation of phage T12 DNA. The serotype M12 strain CS24 was used
as a noninvasive control in invasion assays (35).
Mitomycin-induced phage lysates from M1inv+ strain 90-226 (9) were prepared as previously described (35, 40). Lysogens were obtained by streaking bacteria from turbid plaques onto Todd-Hewitt agar medium.
Chromosomal DNAs, used for Southern blots, were extracted from
streptococci as previously described (6). Template
chromosomal DNA for PCR was extracted by a rapid, microwave extraction
method (3). DNA probes for Southern blots were labelled with
digoxigenin. Hybridization conditions and the methods for detection of
hybrids are described in the Genius System user's guide (Boehringer
Mannheim Biochemicals). Phage particles, extraction, and purification
of phage DNA were described previously by Yu and Ferretti
(40). The probe used to identify speA sequence
was produced by PCR. The speA primers were speaFor
(5'TTTAAATCTAGAGGAGA ACCCAGATATAAAATGGAGG3') and speaRev
(5'GACGATAAAA TAGTTGCTAAGCTACAAGCTCCTG3') (6). The product from these primers extends beyond the 3' end of the speA gene by 271 nucleotides. A gentamicin-penicillin
resistance intracellular invasion assay was used to determine the
frequency of internalization of streptococci by cultured A549 cells
(22).
The M1inv+ subclone carries a T12-like prophage.
Earlier
studies showed that the M1inv+ subclone harbored the speA gene (5,
27-29, 36); therefore, M1inv+ cultures were presumed to harbor a
T12-like prophage that is not present in the M1inv
strains. To
explore this possibility, Southern blots of genomic DNA from 58 M1
clinical isolates, with and without the invasive restriction profile
(5), were probed with digoxigenin-labelled phage T12 DNA.
Figure 1 shows representative results.
Multiple HaeIII restriction fragments from 47 strains with
the invasive restriction profile, whether isolated from systemic
disease or uncomplicated infections, hybridized to the probe (Fig. 1A).
Phage T12 DNA was included for comparison. The T12 and T14
bacteriophages are highly related but not identical (Fig. 1A and
2). Estimations of the size of the T14
genome obtained by summing the sizes of hybridizing fragments
approached 36 kb. An asterisk marks a fragment of speA. At
least two fragments are chromosomal junction fragments, so 36 kb
exceeds the actual size of the phage T14 genome. DNAs from M1inv+
strains from Finland and New Zealand also harbored the same prophage.
The hybridizing fragments were identical to those from North America,
confirming that the M1inv+ subclone associated with serious disease was
globally dispersed (data not shown). A recent analysis of Scandinavian
strains showed that this strain waxed and waned in dominance and in
being the cause of systemic infections between 1988 and 1995 (26). As predicted, DNA from 11 M1inv
strains lacked a
T12-like prophage (Fig. 1B). Strain T253c DNA was included as a
negative control. The phage T12 probe weakly hybridized to DNA
fragments in T253c and M1inv
DNAs. These weaker signals were due to
the fact that T253c, although cured of plaque-forming phage, retains a
defective prophage that contaminates all phage lysates prepared in this
strain (40). Yu et al. suggested that this or a related
defective phage was present in most clinical isolates of group A
streptococci (40).

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 1.
Southern hybridization of restricted DNAs from M1inv+
and M1inv clinical isolates to dioxigenin-labelled phage DNAs. Strain
T253c has been cured of phage T12 and other plaque-forming phages. (A)
HaeIII-digested DNAs were probed with digoxigenin-labelled
phage T12 DNA. Strains 87-263, 87-442, and L462 are M1inv isolates.
The remaining strains are M1inv+. The asterisk marks an speA
HaeIII fragment. (B) ClaI-digested DNAs from M1inv+
clinical isolates were probed with labelled phage T13 DNA. Strain
T253c(T13) is a T13 lysogen that was purified from a single plaque. (C)
ClaI-digested DNA from M1inv strains probed with labelled
phage T13 DNA. DNA from the M1inv+ strain 90-226 was included as a
positive control. Strain 85-069 was designated M1inv on the basis of
RFLP (data not shown) and because it lacks phage T14.
|
|

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 2.
Southern hybridization of HaeIII-digested DNA
purified from T12, T13, and T14 phage ( ) particles to labelled phage
DNAs. DNA was probed with digoxigenin-labelled phage T12 DNA (A),
labelled phage T14 DNA (B), and phage T13 DNA (C). Arrows mark phage
T12-specific (A) and phage T14-specific (B) fragments.
|
|
M1inv+ strains contain a second plaque-forming bacteriophage.
The prophage carried by two M1inv+ cultures, strains 90-131 and 90-226, were induced by mitomycin and plaqued onto strain T253c. Both large and
small turbid plaques were observed, and these plaques were easily
distinguished from phage T12 plaques. Individual plaques from a
mitomycin-induced culture of strain 90-226 were resuspended and
replated onto strain T253c soft agar lawns. The turbid areas of single
plaques were streaked onto agar media to obtain T253c lysogens,
T253c(T13) from large, highly turbid plaques, and T253c(T14) from
small, lightly turbid plaques. These lysogens were used for the
production of high-titer lysates and phage DNA. Phage T12, T13, and T14
lysogens exhibited different immunities to superinfection (Table
1). Phage T12 formed plaques on M1inv+
cultures and on T253c(T13) and T253c(T14) lysogens. These phages also
have somewhat different temperature optima for plaque formation. Phages
T13 and T12 form plaques at 30 and 37°C, whereas phage T14 plaqued
more efficiently at 30°C. Yu and coworkers described other
T12-related phage with unique immunities and restriction fragment
profiles, indicating a high level of genetic diversity among T12-like
bacteriophages (40).
Preparations of all three phages were contaminated with the defective
phage harbored by T253c. Phages T12 and T13 produced
very high-titered
lysates, whereas phage T14 produced low-titered
lysates that were
heavily contaminated by the defective phage.
Therefore, phage T14 DNA
probes contained nearly equal amounts
of DNA from the defective phage,
complicating hybridization experiments.
Genomic DNAs from M1inv+ and
M1inv

clinical isolates were probed
with labelled phage T13 DNA to
determine whether both carried
this prophage. Phage T13 DNA hybridized
extensively to 13
ClaI
fragments from 9 of 10 M1inv+ DNAs
(Fig.
1B). Strain 90-225 was
the exception; its T13 prophage lacked
several fragments common
to the other strains. As expected, T253c
lacked the T13 prophage.
The weakly hybridizing bands in T253c DNA are
derived from the
defective prophage.
ClaI-digested genomic
DNAs from M1inv

strains
were also probed with phage T13 DNA (Fig.
1C). Seven of eight
of these strains lacked T13 prophage DNA. M1inv

strain 85-069
contained a T13 prophage but did not harbor the T14
prophage,
suggesting that phage T13 has been transmitted between
different
M1 subclones. The phage T13 probe hybridized weakly to four
large
ClaI fragments, suggesting that M1inv

strains carry
a prophage
that is related to phage T13 or to the T253c-defective
phage.
Since phage T14 DNA hybridizes to the same fragments, the latter
explanation is likely to be correct. Genomic DNA from an M1inv+
strain,
90-226, was included as a positive control for T13 prophage.
Phages T12 and T14 are highly similar and unrelated to phage
T13.
DNAs extracted from phage particles were probed in order to
investigate genomic similarities between T12, T13, and T14
bacteriophages (Fig. 2). As expected, the T12 probe hybridized
extensively to HaeIII digests of itself and phage T14 DNA
but did not hybridize to phage T13 DNA (Fig. 2A). The T14 probe
hybridized extensively to phage T12 DNA and to itself (Fig. 2B) but did
not hybridize to phage DNA from 90-226 cultures because the ratio of
phage T13 to T14 in induced 90-226 cultures approached 2 × 105:1. The few phage T14 HaeIII fragments that
weakly hybridized to phage T13 DNA correspond to the defective-phage
DNA that contaminates both DNA preparations. The phage T13 probe
hybridized to itself and to a mixture of phage DNAs obtained from a
mitomycin-induced culture of 90-226 (Fig. 2C). Phage T12 and T14 DNAs
did not hybridize to the T13 DNA probe, indicating that these phages
are unrelated to phage T13. Estimations of the genomic sizes of T14 and
T13 genomes from hybridizing fragments on agarose gels were 36 and 34.5 kb, respectively.
Phage DNAs were probed with a labelled fragment of the
speA
gene that was produced by PCR to determine which phage encoded
the
speA gene.
HaeIII-,
ClaI-, and
EcoRI-digested phage T12 and
T14 DNAs hybridized to the
speA probe (Fig.
3). The
speA gene
contains one
HaeIII site, one
ClaI site, and no
EcoRI sites (
18,
38). As expected, two
HaeIII fragments, two
ClaI fragments,
and one
EcoRI fragment from the
T12 and T14 DNAs produced signals.
The smaller
speA HaeIII
and
ClaI fragments were the same size
in phages T12 and T14.
The larger
speA fragments differed in size
and hybridization
intensity, suggesting that sequence adjacent
to one side of
speA was not the same in both phages. Restricted
phage T13
DNA did not hybridize to the
speA probe under the same
conditions. With longer exposures, a 3.1-kb
ClaI fragment of
T13
DNA hybridized weakly to the
speA and phage T12 and T14
probes.
This fragment was cloned and sequenced to determine its
relationship
to
speA. The sequence revealed that
cross-hybridization between
phage T13 DNA and the
speA probe
was due to the presence of a
152-bp DNA segment that was 72% similar
to a region immediately
3' to
speA (data not shown). While
this result indicated that
phage T13 did not possess an
speA
gene, it suggested that phage
T13 may have acquired a host gene(s) that
was closely linked to
the ancestral
speA gene acquired by
phage T12.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 3.
Southern hybridization of restricted phage DNAs to a
labelled PCR fragment that corresponds to a segment of the
speA gene. Enzymes used for restriction digests are
indicated at the top. Phage 90-226 ( 90-226), phage DNA isolated from
mitomycin-induced cultures of strain 90-226. Although this strain
harbors both T13 and T14 phages, induced lysates contain predominately
T13 particles.
|
|
The discovery that M1inv+ strains carry two different prophages,
contributing 70.5 kb of DNA sequence that is not present
in M1inv

strains, further supports the claim that the former
represents a
phylogenetically distinct subclone. Numerous reports
have documented
reassortment and recombination between genetic
loci in group A
streptococci (
4,
15,
31,
39). Although
lateral movement of
exotoxin genes
speA (
18,
38,
41) and
speC (
12) was clearly demonstrated to be mediated
by converting
temperate bacteriophages, it is not known which
mechanisms are
responsible for horizontal transfer of other chromosomal
genes.
Transposons and plasmids are seldom identified in group A
streptococci.
Since most, if not all, strains of group A streptococci
contain
temperate phage (
40), it is reasonable to assume
that they are
the most-common vehicles of genetic exchange. Acquisition
of one
or more bacteriophages greatly increases the genetic potential
of an organism and could substantially increase the fitness of
a
subclone in humans.
The M1inv+ subclone invades epithelial cells more efficiently than
other M1 subclones.
Group A streptococci have been shown to invade
epithelial cells at a high frequency (9, 13, 14, 22, 33).
Expression of M protein or a fibronectin binding protein was
demonstrated to be sufficient for efficient ingestion of these
streptococci (9, 14, 25). Cultured lung epithelial cells
were shown to much more efficiently internalize an M1inv+ strain than
an M1inv
culture (22), suggesting that prophage carried by
the former may be responsible for the more-invasive phenotype. The capacities of a variety of M1inv+ and M1inv
clinical isolates to
invade A549 cells were compared in order to confirm this initial observation (Fig. 4). Although the
invasion frequency varied considerably from day to day, M1inv+ cultures
invaded these epithelial cells at significantly higher frequencies than
did M1inv
cultures. This variability prompted us to perform an
experiment in which the genotype of the strains was concealed (Fig. 4,
open symbols). The variability associated with strain 90-131 is the
result of genetic instability in expression of the Vir regulon
(6). High- and low-frequency internalization correlated with
the genotype of the strain and did not reflect the source of the
culture.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
Internalization of M1 clinical isolates by lung
epithelial A549 cells. Monolayers were infected with approximately
105 CFU of each culture. Internalized streptococci were
determined by viable counts following 2 h of exposure to
gentamicin and penicillin (22). Circles indicate M1inv+
strains. Stippled circles, M1inv+ strains isolated from patients with
uncomplicated disease; triangles, M1inv strains isolated from
patients with uncomplicated pharyngitis. Strain 85-069 is M1inv but
harbors phage T13. Open circles and triangles represent strains whose
genotypes were unknown to the investigator at the time of the
experiment. NA, not available.
|
|
Serial passage of an M1inv+ strain through cultured epithelial cells
enriched for streptococci that invaded cells at a higher
frequency,
whereas passage of an M1inv

strain had no effect on
its invasive
phenotype (
6), suggesting that M1inv

strains
lacked the
genetic potential to revert to a highly invasive phenotype
and
prompting us to test whether the T13 or T14 prophage could
increase the
low frequency of invasion of a laboratory strain.
This was explored by
comparing the invasion efficiencies of T253c
lysogens. No differences
were observed between the frequency of
the parent strain, T253c, and
those of T253c(T13), T253c(T12),
and T253c(T14), single lysogens, or
that of T253c(T13, T14), a
double lysogen.
Lysogeny by temperate bacteriophages can enhance bacterial virulence by
a number of different mechanisms. Bacteriophages can
encode proteins
that contribute to adherence, serum resistance,
and antigenic variation
of bacterial hosts. The production of
SpeA has been associated with
severe streptococcal infection.
Whether this toxin acts alone or in
concert with other superantigens
is debatable. Assuming that SpeA
contributes to the pathogenesis
of toxic shock, the dissemination of
phage T14 or other T12-like
phage has the potential to significantly
influence the epidemiology
of streptococcal infections. Whether this
phage encodes additional
factors that contribute to the propensity of
streptococci to cause
serious disease is unclear. The retention of
phage T13 by M1inv+
strains suggests that this phage may also confer a
selective advantage
on streptococci.
Cockerill et al. discovered that 30% of schoolchildren in a southern
Minnesota community carried the same subclone of M3 group
A
streptococci that was associated with an outbreak of invasive
disease
and several deaths among adults in the same region (
7).
Others have noted that the most-common subclone of a given serotype
isolated from cases of uncomplicated pharyngitis is also the subclone
that is most-often associated with invasive disease (
17).
The
carriage of streptococci by healthy individuals and the frequent
persistence of these bacteria in the throat after vigorous antibiotic
therapy is well documented but not understood (
11). No
clinical
isolate of group A streptococci has been documented to be
genetically
resistant to penicillin (
20), yet 10 to 30% of
individuals retain
this organism in their throats after a 10-day course
of penicillin.
Our observation that M1inv+ strains are internalized
into a penicillin-impervious
compartment of cultured epithelial cells
at a significantly higher
frequency than other strains could account
for the persistence
and widespread dissemination of this subclone. A
strain with greater
potential to be internalized by mucosal or
tonsillar tissue may
better resist many antibiotics and continue to be
spread to others
in the community. Data reported by Österlund et
al. are consistent
with this explanation (
30). These
researchers demonstrated that
13 of 14 tonsils that were removed from
children plagued by recurrent
pharyngitis contained intracellular
streptococci. Tonsils removed
from healthy adults for other unrelated
reasons did not contain
intracellular streptococci. In a recent
comparison of streptococcal
isolates from a variety of patients,
Molinari and Chhatwal observed
that isolates from carriers invaded Hep2
cells at a higher frequency
than blood isolates (
25). We did
not observe a correlation between
the frequency with which epithelial
cells are invaded and the
origin of the culture. High-frequency
invasion correlated only
with genotype. Our collection, however, did
not contain strains
from carriers. Based on Molinari and Chhatwal's
study, we predict
that carriers may shed the M1inv+ subclone more
frequently than
strains that are poorly internalized by epithelial
cells.
The globally disseminated M1inv+ subclone, also termed Ia
(
28) and d3B (
26), can be distinguished from
other serotype
M1 strains by its
emm1,
speB,
speA,
ska, and
scpA alleles (
21,
28). Moreover, this subclone also efficiently invades human
epithelial cells and harbors two prophages, or nearly 70 kb of
DNA
sequence

potentially 50 to 60 genes. Both characteristics
could affect
the propensity of this subclone to cause serious
infections and its
dissemination in humans.
 |
ACKNOWLEDGMENTS |
This study was financed by a grant from the Public Health Service
(AI34503), and D.C. was supported by Public Health Service training
grant AI07421.
We thank Patrick Schlievert, Edward Kapland, H. Seppälä,
and Diane Martin for supplying us with M1 clinical isolates and Tim
Leonard for his assistance with the presentation of our data.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Box 196 UMHC,
Department of Microbiology, University of Minnesota, Minneapolis, MN 55455. Phone: (612) 624-6190. Fax: (612) 626-0623. E-mail:
cleary{at}lenti.med.umn.edu.
Editor:
V. A. Fischetti
 |
REFERENCES |
| 1.
|
Abolnik, I. Z., and D. J. Sexton.
1994.
Necrotizing fasciitis and myositis caused by group A streptococci. Epidemiology, diagnosis, and treatment of "flesh-eating bacteria."
N.C. Med. J.
55:464-466.
|
| 2.
|
Beall, B.,
R. Facklam,
T. Hoenes, and B. Schwartz.
1997.
Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995.
J. Clin. Microbiol.
35:1231-1235[Abstract].
|
| 3.
|
Bollet, C.,
M. J. Gevaudan,
X. de Lamballerie,
C. Zandotti, and P. de Micco.
1991.
A simple method for the isolation of chromosomal DNA from Gram+ or acid-fast bacteria.
Nucleic Acids. Res.
19:1955[Free Full Text].
|
| 4.
|
Cleary, P. P.,
D. Johnson, and L. W. Wannamaker.
1979.
Genetic variation in the M antigen of group A streptococci: reassortment of type-specific markers and possible antigenic drift.
J. Infect. Dis.
140:747-757[Medline].
|
| 5.
|
Cleary, P. P.,
E. L. Kaplan,
J. P. Handley, et al.
1992.
Clonal basis for resurgence of serious streptococcal disease in the 1980's.
Lancet
321:518-521.
|
| 6.
|
Cleary, P. P.,
L. McLandsborough,
L. Ikeda,
D. Cue,
J. Krawezak, and H. Lam.
1998.
High frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci.
Mol. Microbiol.
28:157-167[Medline].
|
| 7.
|
Cockerill, F. R.,
L. Kristine,
M. D. MacDonald, et al.
1997.
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children.
JAMA
277:38-43[Abstract/Free Full Text].
|
| 8.
|
Coleman, G.,
A. Tanna,
A. Efstratiou, and E. Gaworzewska.
1993.
The serotypes of Streptococcus pyogenes presented in Britain during 1980-1990 and their association with disease.
J. Med. Microbiol.
39:165-178[Abstract/Free Full Text].
|
| 9.
|
Cue, D.,
P. E. Dombek,
H. Lam, and P. P. Cleary.
1998.
Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells.
Infect. Immun.
66:4593-4601[Abstract/Free Full Text].
|
| 10.
|
Gamba, M. A.,
M. Martinelli,
H. J. Schaad, et al.
1997.
Familial transmission of a serious disease-producing group A streptococcal clone: case reports and reviews.
Clin. Infect. Dis.
24:1118-1121[Medline].
|
| 11.
|
Gerber, M.
1994.
Treatment failures and carriers: perception of problems?
Pediatr. Infect. Dis. J.
13:576-579[Medline].
|
| 12.
|
Goshorn, S. C., and P. M. Schlievert.
1989.
Bacteriophage association of streptococcal pyrogenic exotoxin C.
Infect. Immun.
171:3068-3073.
|
| 13.
|
Greco, R.,
L. De Martino,
G. Donnarumma,
M. P. Conte,
L. Seganti, and P. Valenti.
1995.
Invasion of cultured human cells by Streptococcus pyogenes.
Res. Microbiol.
146:5551-5560.
|
| 14.
|
Fluckiger, U.,
K. F. Jones, and V. A. Fischetti.
1998.
Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells.
Infect. Immun.
66:974-979[Abstract/Free Full Text].
|
| 15.
|
Harbaugh, M. P.,
A. Podbielski,
S. Hugl, and P. P. Cleary.
1993.
Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein.
Mol. Microbiol.
8:981-991[Medline].
|
| 16.
|
Johnson, D. R.,
D. L. Stevens, and E. L. Kaplan.
1992.
Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.
J. Infect. Dis.
166:374-382[Medline].
|
| 17.
|
Johnson, D. R.,
C. L. Romana,
C. D. Rehder,
J. Dehnbostel, and E. L. Kaplan.
1997.
Restriction enzyme analysis (REA) of group A streptococcal (GAS) M-serotypes 1, 3, and 28, p. 221-223.
In
T. Horaud (ed.), Streptococci and the host. Plenum Press, New York, N.Y.
|
| 18.
|
Johnson, L. P., and P. M. Schlievert.
1983.
A physical map of the group A streptococcal pyrogenic exotoxin bacteriophage genome.
Mol. Gen. Genet.
189:251-255[Medline].
|
| 19.
|
Johnson, L. P., and P. M. Schlievert.
1984.
Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A.
Mol. Gen. Genet.
194:52-56[Medline].
|
| 20.
|
Kaplan, E. L.
1997.
Recent evaluation of antimicrobial resistance in -hemolytic streptococci.
Clin. Infect. Dis.
24:S89-S92.
|
| 21.
|
Kapur, V.,
S. Kanjilal,
M. R. Hamrick, et al.
1995.
Molecular population analysis of the streptokinase gene of Streptococcus pyogenes: mosaic alleles generated by recombination.
Mol. Microbiol.
16:509-519[Medline].
|
| 22.
|
LaPenta, D.,
C. Rubens,
E. Chi, and P. P. Cleary.
1994.
Group A streptococci efficiently invade human respiratory epithelial cells.
Proc. Natl. Acad. Sci. USA
91:12115-12119[Abstract/Free Full Text].
|
| 23.
|
Martin, D. R., and L. A. Single.
1993.
Molecular epidemiology of group A streptococcus M type 1 infections.
J. Infect. Dis.
167:1112-1117[Medline].
|
| 24.
|
Martin, P. R., and E. A. Hoiby.
1990.
Streptococcal serogroup A epidemic in Norway 1987-1988.
Scand. J. Infect. Dis.
22:421-429[Medline].
|
| 25.
|
Molinari, G., and G. Chhatwal.
1998.
Invasion and survival of Streptococcus pyogenes in eukaryotic cells correlates with the source of the clinical isolates.
J. Infect. Dis.
177:1600-1607[Medline].
|
| 26.
|
Muotiala, H.,
H. Seppälä,
P. Huovinen, and J. Vuopio-Varkila.
1997.
Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland.
J. Infect. Dis.
175:392-399[Medline].
|
| 27.
|
Musser, J. M.,
A. R. Hauser,
M. H. Kim,
P. M. Schlievert,
K. Nelson, and R. K. Selander.
1991.
Streptococcus pyogenes causing toxic shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.
Proc. Natl. Acad. Sci. USA
88:2668-2672[Abstract/Free Full Text].
|
| 28.
|
Musser, J. M.,
V. Kapur,
J. Szeto,
X. Pan,
D. S. Swanson, and D. R. Martin.
1995.
Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.
Infect. Immun.
63:994-1003[Abstract].
|
| 29.
|
Nelson, K.,
P. M. Schlievert,
R. K. Selander, and J. M. Musser.
1991.
Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes.
J. Exp. Med.
174:1271-1274[Abstract/Free Full Text].
|
| 30.
|
Österlund, A.,
R. Popa,
T. Nikkila,
A. Scheynius, and L. Engstrand.
1997.
Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis.
Laryngoscope
107:640-647[Medline].
|
| 31.
|
Podbielski, A.,
J. Hawlitzky,
T. D. Pack, and A. Flosdorff.
1994.
A group A streptococcal enn protein potentially resulting from intergenomic recombination exhibits atypical immunoglobulin-binding characteristics.
Mol. Microbiol.
12:725-736[Medline].
|
| 32.
|
Schlievert, P. M.,
A. P. Assimacopoulos, and P. P. Cleary.
1996.
Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis.
J. Lab. Clin. Med.
127:13-22[Medline].
|
| 33.
|
Schrager, H. M., and M. R. Wessels.
1997.
Hyaluronic acid capsule modulates interactions of group A streptococci with human epidermal keratinocytes.
Adv. Exp. Med. Biol.
418:517-523[Medline].
|
| 34.
|
Seppälä, H.,
J. Vuopio-Varkila,
M. Osterblad, et al.
1994.
Evaluation of methods for epidemiologic typing of group A streptococci.
J. Infect. Dis.
169:519-525[Medline].
|
| 35.
|
Spanier, J., and P. P. Cleary.
1983.
A restriction map and analysis of the terminal redundancy in the group A streptococcal bacteriophage SP24.
Virology
130:502-513[Medline].
|
| 36.
|
Stevens, D. L.,
M. H. Tanner,
J. Winship,
R. Swarts,
K. Ries,
P. Schlievert, and E. Kapland.
1989.
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.
N. Engl. J. Med.
321:1-7[Abstract].
|
| 37.
|
Talkington, D. F.,
B. Schwartz,
C. M. Black,
J. K. Todd,
J. Elliott,
R. F. Breiman, and R. R. Facklam.
1993.
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome.
Infect. Immun.
61:3369-3374[Abstract/Free Full Text].
|
| 38.
|
Weeks, C. R., and J. J. Ferretti.
1984.
The gene for type A streptococcal exotoxin (erythrogenic toxin) is located in bacteriophage T12.
Infect. Immun.
46:531-536[Abstract/Free Full Text].
|
| 39.
|
Whatmore, A.,
V. Kapur,
D. J. Sullivan,
J. M. Musser, and M. A. Kehoe.
1994.
Non-congruent relationships between variation in gene sequences and the population genetic structures of group A streptococci.
Mol. Microbiol.
14:619-631[Medline].
|
| 40.
|
Yu, C., and J. J. Ferretti.
1991.
Molecular characterization of new group A streptococcal bacteriophages containing the gene for streptococcal erythrogenic toxin (speA).
Mol. Gen. Genet.
231:161-168[Medline].
|
| 41.
|
Zabriskie, J.
1964.
The role of temperate bacteriophage in the production of erythrogenic toxin by group A streptococci.
J. Exp. Med.
119:761-780[Abstract].
|
Infection and Immunity, November 1998, p. 5592-5597, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nooh, M. M., El-Gengehi, N., Kansal, R., David, C. S., Kotb, M.
(2007). HLA Transgenic Mice Provide Evidence for a Direct and Dominant Role of HLA Class II Variation in Modulating the Severity of Streptococcal Sepsis. J. Immunol.
178: 3076-3083
[Abstract]
[Full Text]
-
Kwinn, L. A., Khosravi, A., Aziz, R. K., Timmer, A. M., Doran, K. S., Kotb, M., Nizet, V.
(2007). Genetic Characterization and Virulence Role of the RALP3/LSA Locus Upstream of the Streptolysin S Operon in Invasive M1T1 Group A Streptococcus. J. Bacteriol.
189: 1322-1329
[Abstract]
[Full Text]
-
Smith, N. L., Taylor, E. J., Lindsay, A.-M., Charnock, S. J., Turkenburg, J. P., Dodson, E. J., Davies, G. J., Black, G. W.
(2005). Structure of a group A streptococcal phage-encoded virulence factor reveals a catalytically active triple-stranded {beta}-helix. Proc. Natl. Acad. Sci. USA
102: 17652-17657
[Abstract]
[Full Text]
-
Kristian, S. A., Datta, V., Weidenmaier, C., Kansal, R., Fedtke, I., Peschel, A., Gallo, R. L., Nizet, V.
(2005). D-Alanylation of Teichoic Acids Promotes Group A Streptococcus Antimicrobial Peptide Resistance, Neutrophil Survival, and Epithelial Cell Invasion. J. Bacteriol.
187: 6719-6725
[Abstract]
[Full Text]
-
Aziz, R. K., Edwards, R. A., Taylor, W. W., Low, D. E., McGeer, A., Kotb, M.
(2005). Mosaic Prophages with Horizontally Acquired Genes Account for the Emergence and Diversification of the Globally Disseminated M1T1 Clone of Streptococcus pyogenes. J. Bacteriol.
187: 3311-3318
[Abstract]
[Full Text]
-
Wei, L., Pandiripally, V., Gregory, E., Clymer, M., Cue, D.
(2005). Impact of the SpeB Protease on Binding of the Complement Regulatory Proteins Factor H and Factor H-Like Protein 1 by Streptococcus pyogenes. Infect. Immun.
73: 2040-2050
[Abstract]
[Full Text]
-
Ikebe, T., Wada, A., Inagaki, Y., Sugama, K., Suzuki, R., Tanaka, D., Tamaru, A., Fujinaga, Y., Abe, Y., Shimizu, Y., Watanabe, H., the Working Group for Group A Streptococci in Japa,
(2002). Dissemination of the Phage-Associated Novel Superantigen Gene speL in Recent Invasive and Noninvasive Streptococcus pyogenes M3/T3 Isolates in Japan. Infect. Immun.
70: 3227-3233
[Abstract]
[Full Text]
-
Rudney, J. D., Chen, R., Sedgewick, G. J.
(2001). Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in Buccal Epithelial Cells Collected from Human Subjects. Infect. Immun.
69: 2700-2707
[Abstract]
[Full Text]
-
Chaussee, M. S., Cole, R. L., van Putten, J. P. M.
(2000). Streptococcal Erythrogenic Toxin B Abrogates Fibronectin-Dependent Internalization of Streptococcus pyogenes by Cultured Mammalian Cells. Infect. Immun.
68: 3226-3232
[Abstract]
[Full Text]